Lifting the fog in intermediate-risk (submassive) PE: full dose, low dose, or no thrombolysis?

F1000Res · 2019 · PMC6436190 · PMID 30984375

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

Nevertheless, patients in the treatment arm were found to have a greater reduction in PASP compared with the control group, and although long-term functional outcomes were not formally assessed, these results may be significant in this regard.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.